Stay updated on CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial
Sign up to get notified when there's something new on the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page.

Latest updates to the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedNew history entry on 2025-11-21 adds a Study Status update with Revision v3.3.2. The older revision v3.2.0 (2025-06-05) is removed from the history.SummaryDifference0.5%

- Check20 days agoChange DetectedThe banner notice about government funding lapse and operating status has been removed from the page. This changes the visibility of information about data availability and site operation on the page.SummaryDifference0.7%

- Check34 days agoChange DetectedMinor layout adjustments in the new screenshot while the version history list and study status entries remain the same; no substantive content additions or deletions were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedMajor update to core page content: adds a government funding notice and current operating status details, plus a version bump to v3.2.0; removes the previous v3.1.0 reference.SummaryDifference12%

- Check70 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.3%

- Check84 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.7%

Stay in the know with updates to CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page.